These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 150065)

  • 1. Experimental study of biosoluble drugs. Thrombus lysis with biosoluble immobilized fibrinolysin in experiment.
    Chazov EI; Mazaev AV; Torchilin VP; Lebedev BS; Il'ina EV; Smirnov VN
    Thromb Res; 1978 May; 12(5):809-16. PubMed ID: 150065
    [No Abstract]   [Full Text] [Related]  

  • 2. The thrombolytic effect of miniplasmin in a canine model of femoral artery thrombosis.
    Fu J; Ren J; Zou L; Bian G; Li R; Lu Q
    Thromb Res; 2008; 122(5):683-90. PubMed ID: 18328540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of venous clots by local intraarterial Thrombolysin injection in the rat.
    Dellon AL; Curtis RM; Cooley BC
    Ann Plast Surg; 1981 Jul; 7(1):38-43. PubMed ID: 6455960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on fibrinolytic agent-platelet interaction (author's transl)].
    Mishina Y; Watada M
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):154-60. PubMed ID: 4277931
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of sodium citrate and an excess of plasminogen on fibrinolytic agents.
    ASTRUP T; STERNDORFF I
    Thromb Diath Haemorrh; 1960 Jun; 4():462-72. PubMed ID: 13794908
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombelastographic patterns of ancrod and thrombin fibrin formation and dissolution.
    Caprini JA; Kwaan HC; Zuckerman L; Verduin R
    Thromb Res; 1974 Feb; 4(2):199-217. PubMed ID: 4275415
    [No Abstract]   [Full Text] [Related]  

  • 8. Research on the mechanism of synthetic thrombolytic agents.
    Desnoyers P; Labaume J; Conard J; Samama M
    Acta Univ Carol Med Monogr; 1972; 52():33-40. PubMed ID: 4273930
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the heterogeneity of fibrinolytic activity in artificially induced intravascular clots.
    Ban I
    Nagoya J Med Sci; 1967 Jun; 30(1):37-57. PubMed ID: 4229316
    [No Abstract]   [Full Text] [Related]  

  • 10. Degradation of non cross-linked and cross-linked fibrin clots by plasmin, trypsin, chymotrypsin and Brinase.
    Gormsen J; Feddersen C
    Thromb Res; 1974 Aug; 5(2):125-39. PubMed ID: 4278050
    [No Abstract]   [Full Text] [Related]  

  • 11. Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system.
    Bizjak N; Bajd F; Vidmar J; Blinc A; Perme MP; Marder VJ; Novokhatny V; Serša I
    Thromb Res; 2014 May; 133(5):908-13. PubMed ID: 24613694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysis of arterial clots. Using fibrinolysin in an isolation perfusion system.
    Wagner DE; Polishook RD; Baue AE; Blakemore WS
    Arch Surg; 1965 Nov; 91(5):712-5. PubMed ID: 4221212
    [No Abstract]   [Full Text] [Related]  

  • 13. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON BLOOD COAGULATION IN DOGS.
    LEWIS JH; SHIRAKAWA M
    Am J Physiol; 1964 Nov; 207():1049-52. PubMed ID: 14237448
    [No Abstract]   [Full Text] [Related]  

  • 14. A method to correct for the continuing activation during the second stage in a two-stage assay. Exemplified by urokinase activation of plasminogen determined by the lysis time method.
    Berg W
    Thromb Diath Haemorrh; 1968 Mar; 19(1):161-8. PubMed ID: 4231459
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fibrinolytic and thrombolytic properties of plasmin (a preparation of streptolyase-activated plasminogen)].
    Andreenko GV; Murav'eva NF; Kanygina ED; Liutova LV; Karabasova MA
    Gematol Transfuziol; 1986 Mar; 31(3):27-32. PubMed ID: 2941333
    [No Abstract]   [Full Text] [Related]  

  • 16. [On thrombolysis with various thrombolytic agents. I. Studies on experimental human natural blood clots].
    Schmidt HW
    Klin Wochenschr; 1966 Jun; 44(11):618-21. PubMed ID: 4229084
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of brinase and thrombolysin on the electrochemical, nature of the cardiovascular system of experimental animals (dogs and rabbits).
    Sawyer PN
    Thromb Res; 1977 Mar; 10(3):531-6. PubMed ID: 140475
    [No Abstract]   [Full Text] [Related]  

  • 18. Lysis of thrombi produced by sodium morrhuate in the femoral vein of dogs by human plasmin (fibrinolysin).
    CLIFFTON EE; GROSSI CE; CANNAMELA D
    Ann Surg; 1954 Jan; 139(1):52-62. PubMed ID: 13114851
    [No Abstract]   [Full Text] [Related]  

  • 19. [The research of thrombolytic and hemolysis effect from Eupolyphage fibrinolyric protein and its inhibitory effect on S180 ascites tumor of mice].
    Li ZW; Han YL; Liu H; Ding H
    Zhong Yao Cai; 2010 Jun; 33(6):859-63. PubMed ID: 21049605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Solubility of collagen in fibrinolytic agents].
    Schmitt W; Beneke G
    Klin Wochenschr; 1972 Mar; 50(6):335-7. PubMed ID: 4338646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.